IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.661
AS - Asia 6.891
EU - Europa 5.319
SA - Sud America 1.404
Continente sconosciuto - Info sul continente non disponibili 380
AF - Africa 148
OC - Oceania 5
Totale 31.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.391
SG - Singapore 3.086
CN - Cina 1.553
UA - Ucraina 1.543
BR - Brasile 1.083
DE - Germania 802
HK - Hong Kong 740
FI - Finlandia 621
IT - Italia 594
VN - Vietnam 456
RU - Federazione Russa 387
FR - Francia 378
SE - Svezia 336
IE - Irlanda 257
IN - India 167
TR - Turchia 166
GB - Regno Unito 165
CA - Canada 160
KR - Corea 158
BD - Bangladesh 116
AR - Argentina 92
IQ - Iraq 76
CO - Colombia 68
MX - Messico 49
EC - Ecuador 46
PK - Pakistan 43
ID - Indonesia 40
ZA - Sudafrica 39
JP - Giappone 36
PL - Polonia 34
UZ - Uzbekistan 31
SA - Arabia Saudita 30
VE - Venezuela 30
IR - Iran 29
NL - Olanda 29
CL - Cile 26
CZ - Repubblica Ceca 26
MA - Marocco 26
ES - Italia 25
PY - Paraguay 22
PH - Filippine 19
AT - Austria 18
BE - Belgio 18
JO - Giordania 17
MY - Malesia 15
AE - Emirati Arabi Uniti 13
EU - Europa 13
EG - Egitto 12
KE - Kenya 12
KZ - Kazakistan 12
PE - Perù 12
UY - Uruguay 12
BO - Bolivia 11
TG - Togo 11
AZ - Azerbaigian 10
IL - Israele 10
JM - Giamaica 10
RO - Romania 10
TN - Tunisia 10
OM - Oman 9
TT - Trinidad e Tobago 9
AL - Albania 8
BG - Bulgaria 8
DZ - Algeria 8
RS - Serbia 8
BH - Bahrain 7
CR - Costa Rica 7
HN - Honduras 7
KG - Kirghizistan 7
LT - Lituania 7
HU - Ungheria 6
LB - Libano 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
GE - Georgia 5
PS - Palestinian Territory 5
AU - Australia 4
ET - Etiopia 4
GR - Grecia 4
LV - Lettonia 4
NP - Nepal 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
PA - Panama 3
RW - Ruanda 3
TH - Thailandia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BJ - Benin 2
CG - Congo 2
CI - Costa d'Avorio 2
GA - Gabon 2
GL - Groenlandia 2
GT - Guatemala 2
Totale 31.395
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.115
Ann Arbor 1.688
Singapore 1.265
Fairfield 1.223
Houston 1.199
Jacksonville 1.110
Ashburn 1.029
San Jose 953
Beijing 841
Chandler 762
Hong Kong 732
Dearborn 590
Wilmington 506
Council Bluffs 477
Seattle 453
Cambridge 374
Boardman 321
Dublin 255
Princeton 255
Lauterbourg 238
Los Angeles 233
Dallas 187
Ho Chi Minh City 155
Seoul 146
Hefei 143
Buffalo 133
Udine 113
Izmir 111
Munich 110
Santa Clara 110
San Diego 102
New York 99
Helsinki 95
São Paulo 90
Hanoi 88
Ottawa 77
Trieste 66
The Dalles 63
Ogden 62
Norwalk 56
Orem 55
Turku 46
Des Moines 45
Redondo Beach 45
Rio de Janeiro 41
Phoenix 37
Nanjing 35
Tokyo 35
Montreal 34
Mumbai 34
Milan 33
Baghdad 32
Warsaw 30
Frankfurt am Main 29
Regensburg 29
Kunming 28
Tashkent 28
Atlanta 26
Toronto 26
Chennai 25
Chicago 25
Dong Ket 25
Pittsburgh 25
Porto Alegre 25
Belo Horizonte 24
Rome 23
Guangzhou 22
London 22
Brasília 21
Brooklyn 21
Stockholm 21
Bogotá 20
Boston 20
Denver 20
Augusta 19
Da Nang 19
Johannesburg 19
Poplar 19
Simi Valley 19
Brussels 18
Mexico City 18
San Francisco 18
Washington 18
Jinan 17
Nuremberg 17
Quito 17
Amman 16
Andover 15
Curitiba 15
Medellín 15
Istanbul 14
Lahore 14
Leawood 14
Manchester 14
Nanchang 14
Asunción 13
Campinas 13
Guarulhos 13
Haiphong 13
San Mateo 13
Totale 20.046
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 282
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 228
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 225
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 216
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 212
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 209
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 208
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 196
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 185
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 185
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 185
Histone post-translational modifications associated to BAALC expression in leukemic cells. 184
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 184
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 181
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 181
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 181
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 177
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 177
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 174
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 170
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 169
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 169
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 168
A study of the material in the ATLAS inner detector using secondary hadronic interactions 167
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 166
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 163
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 162
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 160
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 160
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 159
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 159
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 158
Epstein-Barr virus (EBV) reactivation in a patient treated with ATG for severe aplastic anemia 158
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 158
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 157
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 156
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 156
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 155
Unexpected phenotype of a typical NPM1 mutant 155
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 154
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 153
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 152
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 150
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 150
ABCB1 (PGP) and ABCG (BCRP) proteins are independent prognostic factors for complete remissione and relapse risk, respectively in normal karyotype adult de novo acute myeloid leukemia. 149
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 148
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 148
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 148
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 147
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 147
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 147
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 145
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 145
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 144
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 144
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 144
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 144
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 144
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 142
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 142
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients 142
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 140
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 140
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 140
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 140
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 139
“CD34+ selected versus un-manipulated autologous stem cell transplantation in multiple myeoloma: impact on dendritic and immune recovery and on complications due to infections”. 139
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 139
Dendritic cell recovery after autologous stem cell transplantation 139
Prognostic factors anad expression of multidrug-resistance related proteins in 36 patients with acute promyelocytic leukemia. 138
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 138
Castleman's disease: an unusual cause of mediastinal mass and anemia. 138
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 138
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 138
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 137
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 137
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 136
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 135
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 134
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 134
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 134
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 134
“The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkins’ Lymphoma patients” 133
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults. 133
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 133
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 133
The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leucemia 131
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 130
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 130
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 130
High dose therapy with stem cell rescue in elderly atients with aggressive poor risk lymphomas: a review of 14 cases. 129
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia 129
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 129
“Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?” 128
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 128
Allogeneic stem cell transplantation as salvage therapy for patients with lymphoma. 128
Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins 128
Isolation, characterization and in vitro growth of human multipotent adult cardiac progenitor cells 128
Teaching students’ patient safety core competencies: results of an Italian program 128
Proliferation and maturation effects of in vivo granulo-monocyte colony stimulating factor in acute non-lymphocytic leucemia”. 127
Totale 15.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.569 0 0 69 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024600 98 58 35 27 71 84 10 33 86 44 13 41
2024/20254.435 87 346 209 117 140 187 262 285 476 247 867 1.212
2025/20268.227 704 779 644 733 1.087 695 1.119 280 614 808 417 347
2026/20271.070 183 507 380 0 0 0 0 0 0 0 0 0
Totale 31.808